Trademark: 88822042
Word
BECIDIGM
Status
Pending
Status Code
734
Status Date
Friday, February 23, 2024
Serial Number
88822042
Mark Type
4000
Filing Date
Thursday, March 5, 2020
Published for Opposition
Tuesday, July 20, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Feb 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2024
Sou Extension 5 Granted
Feb 7, 2024
Sou Extension 5 Filed
Feb 23, 2024
Case Assigned To Intent To Use Paralegal
Feb 7, 2024
Sou Teas Extension Received
Aug 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 29, 2023
Sou Extension 4 Granted
Aug 29, 2023
Sou Extension 4 Filed
Aug 29, 2023
Sou Teas Extension Received
Mar 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2023
Sou Extension 3 Granted
Mar 13, 2023
Sou Extension 3 Filed
Mar 13, 2023
Sou Teas Extension Received
Aug 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2022
Sou Extension 2 Granted
Aug 23, 2022
Sou Extension 2 Filed
Aug 23, 2022
Sou Teas Extension Received
Feb 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2022
Sou Extension 1 Granted
Feb 23, 2022
Sou Extension 1 Filed
Feb 23, 2022
Sou Teas Extension Received
Sep 14, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 20, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 20, 2021
Published For Opposition
Jun 30, 2021
Notification Of Notice Of Publication E-Mailed
Jun 14, 2021
Approved For Pub - Principal Register
Jun 11, 2021
Teas/Email Correspondence Entered
Jun 10, 2021
Correspondence Received In Law Office
Jun 10, 2021
Teas Request For Reconsideration Received
Dec 11, 2020
Notification Of Final Refusal Emailed
Dec 11, 2020
Final Refusal E-Mailed
Dec 11, 2020
Final Refusal Written
Nov 24, 2020
Teas/Email Correspondence Entered
Nov 23, 2020
Correspondence Received In Law Office
Nov 23, 2020
Teas Response To Office Action Received
May 29, 2020
Notification Of Non-Final Action E-Mailed
May 29, 2020
Non-Final Action E-Mailed
May 29, 2020
Non-Final Action Written
May 26, 2020
Assigned To Examiner
Mar 11, 2020
New Application Office Supplied Data Entered
Mar 9, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24